These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2684096)

  • 21. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of Varicella-zoster virus.
    Kutinová L; Hainz P; Ludvíková V; Maresová L; Nĕmecková S
    Virology; 2001 Feb; 280(2):211-20. PubMed ID: 11162835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feline herpesvirus type 1 glycoproteins eliciting virus neutralizing and hemagglutination-inhibiting antibodies.
    Horimoto T; Limcumpao JA; Tohya Y; Takahashi E; Mikami T
    Arch Virol; 1990; 111(1-2):127-32. PubMed ID: 2327898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immune response to infection with vaccinia virus in mice. I. Infection and the production of antibody neutralizing cell-associated and cell-free virus.
    Hutt LM
    J Hyg (Lond); 1975 Jun; 74(3):301-14. PubMed ID: 168248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of early viral surface antigens in cellular immune response to vaccinia virus.
    Koszinowski U; Ertl H
    Eur J Immunol; 1976 Oct; 6(10):679-83. PubMed ID: 65141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.
    Hangartner L; Zellweger RM; Giobbi M; Weber J; Eschli B; McCoy KD; Harris N; Recher M; Zinkernagel RM; Hengartner H
    J Exp Med; 2006 Aug; 203(8):2033-42. PubMed ID: 16880253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells.
    Shimizu Y; Fujiwara H; Ueda S; Wakamiya N; Kato S; Hamaoka T
    Eur J Immunol; 1984 Sep; 14(9):839-43. PubMed ID: 6236991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics.
    Gardner I; Bowern NA; Blanden RV
    Eur J Immunol; 1974 Feb; 4(2):63-7. PubMed ID: 4211857
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation.
    Sastre P; Melero JA; García-Barreno B; Palomo C
    J Med Virol; 2005 Jun; 76(2):248-55. PubMed ID: 15834867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.
    Nick S; Klaws J; Friebel K; Birr C; Hunsmann G; Bayer H
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():77-83. PubMed ID: 1689371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homologous and heterologous glycoproteins induce protection against Junin virus challenge in guinea pigs.
    López N; Scolaro L; Rossi C; Jácamo R; Candurra N; Pujol C; Damonte EB; Franze-Fernández MT
    J Gen Virol; 2000 May; 81(Pt 5):1273-81. PubMed ID: 10769070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity in mice of human metapneumovirus with a truncated SH glycoprotein.
    Tedcastle AB; Fenwick F; Robinson MJ; Toms GL
    J Med Virol; 2014 Apr; 86(4):547-57. PubMed ID: 24009128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of recovery from systemic vaccinia virus infection. I. The effects of cyclophosphamide.
    Worthington M; Rabson AS; Baron S
    J Exp Med; 1972 Aug; 136(2):277-90. PubMed ID: 5043413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence.
    Isaacs SN; Kotwal GJ; Moss B
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):628-32. PubMed ID: 1731333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin reactions to vaccinia virus infection in the rabbits immunized with vaccinia-soluble early antigen.
    Yuasa T; Chino F; Tsuruhara T
    Jpn J Med Sci Biol; 1983 Jun; 36(3):147-56. PubMed ID: 6195379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccinia virus proteins on the plasma membranes of infected cells. II. Expression of viral antigens and killing of infected cells by vaccinia virus-specific cytotoxic T cells.
    Mallon VR; Domber EA; Holowczak JA
    Virology; 1985 Aug; 145(1):1-23. PubMed ID: 3874471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.
    Wild TF; Bernard A; Spehner D; Drillien R
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():359-67. PubMed ID: 1538193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The augmentation of tumor-specific immunity by virus help. I. Demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Shimizu Y; Takai Y; Wakamiya N; Ueda S; Kato S; Hamaoka T
    Eur J Immunol; 1984 Feb; 14(2):171-5. PubMed ID: 6199215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.
    Forrester AJ; Sullivan V; Simmons A; Blacklaws BA; Smith GL; Nash AA; Minson AC
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():369-75. PubMed ID: 1704412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.